KJHP
BIOA

K.J. Harrison & Partners’s BioAmber Inc. BIOA Stock Holding History

K.J. Harrison & Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100,717
Closed -$554K – 222
2016
Q4 		$554K Buy
+100,717
New +$483K 0.22% 128

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

K.J. Harrison & Partners's BIOA Position: Q1 2017 in Review

K.J. Harrison & Partners sold out of BioAmber Inc. (BIOA) in Q1 2017, closing a stake of 100,717 shares — an estimated $554K sold.

K.J. Harrison & Partners first reported a position in BIOA in Q4 2016 and held it in 1 quarter. The position peaked at $554K in Q4 2016. 35 funds tracked by Wall St. Rank hold BIOA as of Q1 2017.

  • K.J. Harrison & Partners reported no remaining BioAmber Inc. position as of Q1 2017 after selling out during the quarter.
  • K.J. Harrison & Partners sold 100,717 BioAmber Inc. shares in Q1 2017, an estimated $554K.
  • K.J. Harrison & Partners first reported a position in BioAmber Inc. in Q4 2016 and held it in 1 quarter.
  • K.J. Harrison & Partners's BioAmber Inc. position peaked at $554K in Q4 2016.
  • 35 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2017.

Based on K.J. Harrison & Partners's 13F filing for Q1 2017, filed 26 Apr 2017.